MedTrace Logo

Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

NCT07183423 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-09-19

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a novel barrier topical product works to treat barrier dysfunction in adults. It will also learn about the safety of the novel barrier topical product. The main questions it aims to answer are:

Does the novel barrier topical product improve skin hydration, skin sebum, redness, and pigmentation? Does it improve subjective dryness and itch? Researchers will compare the novel barrier topical product to petrolatum (a gold standard occlusive barrier repair agent) to see how they are comparable in treating skin barrier dysfunction.

Participants will:

Apply the novel barrier topical product or petrolatum twice a day for 28 days Visit the clinic once a week for checkups and tests Keep a diary of their application of the assigned product

Conditions

Interventions

OTHER

Novel barrier repair topical product

Novel barrier product (containing ceramide, virgin coconut oil, cholesterol)

OTHER

Petrolatum

Petrolatum application

Sponsors & Collaborators

  • Makati Medical Center

    lead OTHER

Principal Investigators

  • Vermen M Verallo Rowell, MD · VMV Skin Research Center & Clinics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2025-09-30
Completion
2025-10-31

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07183423 on ClinicalTrials.gov